THE MOUNT VIEW PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: P81089 | FLEETWOOD, FY7 6HP
Showing results 101-150 of 696
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Spironolactone | 825 | 23.4K | £1.8K | +53.0% ▲ |
| Lactulose | 816 | 414.7K | £3.9K | +147.9% ▲ |
| Hyoscine butylbromide | 812 | 87.6K | £6.0K | +248.4% ▲ |
| 802 | 891 | £1.1K | +264.0% ▲ | |
| Escitalopram | 799 | 23.5K | £1.6K | +180.7% ▲ |
| Methotrexate | 785 | 12.2K | £23.0K | +141.2% ▲ |
| Flucloxacillin sodium | 745 | 28.7K | £1.7K | +65.7% ▲ |
| Topiramate | 728 | 43.2K | £4.5K | +309.6% ▲ |
| Betamethasone valerate | 721 | 52.2K | £4.9K | +87.3% ▲ |
| Alogliptin | 712 | 20.1K | £18.2K | +180.8% ▲ |
| Promethazine hydrochloride | 702 | 25.1K | £2.9K | +96.4% ▲ |
| Rosuvastatin calcium | 680 | 20.0K | £951 | -24.2% ▼ |
| Olanzapine | 678 | 19.8K | £2.9K | +83.0% ▲ |
| Pravastatin sodium | 675 | 19.3K | £936 | +107.9% ▲ |
| Estradiol | 669 | 77.2K | £14.5K | -18.5% ▼ |
| Hydroxocobalamin | 634 | 949 | £2.1K | +31.8% ▲ |
| Nitrofurantoin | 630 | 8,284 | £4.7K | +32.0% ▲ |
| 619 | 319.7K | £3.8K | +134.6% ▲ | |
| Digoxin | 618 | 17.4K | £1.3K | +63.3% ▲ |
| Aripiprazole | 612 | 16.8K | £2.6K | +140.5% ▲ |
| Eplerenone | 611 | 16.9K | £2.0K | +130.4% ▲ |
| Tamsulosin and dutasteride hydrochloride | 606 | 16.8K | £4.6K | +1,633.8% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 602 | 610 | £27.1K | +259.9% ▲ |
| Felodipine | 581 | 17.5K | £2.8K | -2.2% ▼ |
| Cetirizine hydrochloride | 580 | 29.1K | £1.3K | +16.1% ▲ |
| Zopiclone | 574 | 10.8K | £460 | +3.7% ▲ |
| Trimethoprim | 557 | 11.0K | £803 | +172.6% ▲ |
| Bimatoprost | 540 | 4,188 | £3.1K | +263.3% ▲ |
| Other emollient preparations | 540 | 265.7K | £3.4K | -10.1% ▼ |
| Ispaghula husk | 538 | 27.2K | £4.7K | +308.4% ▲ |
| Hydrocortisone | 537 | 19.4K | £2.8K | +19.8% ▲ |
| Fluticasone/umeclidinium/vilanterol | 524 | 524 | £22.2K | +123.5% ▲ |
| Timolol and bimatoprost | 520 | 4,584 | £7.9K | +242.6% ▲ |
| Sumatriptan succinate | 510 | 4,333 | £6.7K | +44.0% ▲ |
| 506 | 529 | £3.6K | +114.2% ▲ | |
| Irbesartan | 503 | 15.7K | £647 | +106.4% ▲ |
| Melatonin | 497 | 32.3K | £11.0K | +49.5% ▲ |
| 487 | 51.0K | £1.8K | +76.1% ▲ | |
| Memantine hydrochloride | 486 | 14.9K | £2.7K | +47.1% ▲ |
| Donepezil hydrochloride | 462 | 13.1K | £1.2K | +49.7% ▲ |
| Risperidone | 452 | 21.2K | £2.3K | +78.7% ▲ |
| Ropinirole hydrochloride | 452 | 19.9K | £11.7K | +325.4% ▲ |
| Pramipexole | 447 | 32.1K | £3.0K | +355.3% ▲ |
| Hypromellose | 443 | 5,640 | £1.3K | +234.3% ▲ |
| Sodium valproate | 438 | 35.4K | £6.2K | +37.7% ▲ |
| Piroxicam | 431 | 70.6K | £1.8K | +650.1% ▲ |
| Rivaroxaban | 430 | 14.8K | £9.8K | -29.7% ▼ |
| Latanoprost | 428 | 5,813 | £2.1K | -11.8% ▼ |
| Mesalazine (Systemic) | 420 | 44.7K | £21.1K | +75.3% ▲ |
| Carbomer 940/980 | 420 | 6,790 | £1.4K | +175.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.